 Hepatocarcinoma cirrhosis antithrombin III neoplastic marker hepatoma HCC cells abnormal proteins erytropietin fibrinogen prothrombin antithrombin III AT III preliminary report AT III levels patients HCC independent clinical liver status present study antithrombin III levels serological data present patients cirrhosis patients cirrhosis clinical findings neoplastic disease well-matched patients cirrhosis cirrhosis HCC serum total cholesterol albumin prothrombin alkaline phosphatase AFP AT III AFP alkaline phosphatase patients HCC values AT III total cholesterol ml cirrhotic patients AT III total cholesterol ml difference groups albumin prothrombin aminotransferases HCC patients AT III levels total cholesterol level cirrhotic patients prothrombin level data HCC patients rate synthesis AT III whereas cirrhotic patients levels AT III due impaired synthesis catabolism protein serial determination AT III cirrhotic patients means neoplastic transformation